A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer.
Katsumasa NakamuraKeiji NiheiYoshihiro SaitoNaoto ShikamaShin-Ei NodaRyusuke HaraToshiyuki ImagumbaiTakashi MizowakiTakeshi AkibaEtsuo KuniedaMasanori SomeyaSaiji OhgaJiro KawamoriTakuyo KozukaYosuke OtaKoji InabaTakeshi KodairaYoshiyuki ItohKouta FunakoshiYoshikazu KagamiPublished in: International journal of clinical oncology (2024)
The safety and efficacy of moderately hypofractionated IMRT with prostate-based image-guidance was confirmed among Japanese patients with prostate cancer.